Literature DB >> 12452824

Discovery of immunopotentiatory drugs: current and future strategies.

J Rhodes1.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12452824      PMCID： PMC1906540          DOI： 10.1046/j.1365-2249.2002.02016.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  46 in total

1.  Decoding the patterns of self and nonself by the innate immune system.

Authors:  Ruslan Medzhitov; Charles A Janeway
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  T-cell antigen receptor signal transduction.

Authors:  Doreen A Cantrell
Journal:  Immunology       Date:  2002-04       Impact factor: 7.397

Review 3.  MAP kinases in the immune response.

Authors:  Chen Dong; Roger J Davis; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 4.  Toll-like receptors: mammalian "taste receptors" for a smorgasbord of microbial invaders.

Authors:  Peter A Sieling; Robert L Modlin
Journal:  Curr Opin Microbiol       Date:  2002-02       Impact factor: 7.934

5.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.

Authors:  Marion Jurk; Florian Heil; Jörg Vollmer; Christian Schetter; Arthur M Krieg; Hermann Wagner; Grayson Lipford; Stefan Bauer
Journal:  Nat Immunol       Date:  2002-06       Impact factor: 25.606

6.  Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate.

Authors:  B Eriksson; E Helgstrand; N G Johansson; A Larsson; A Misiorny; J O Norén; L Philipson; K Stenberg; G Stening; S Stridh; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

7.  T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.

Authors:  Maryam Afkarian; John R Sedy; Jianfei Yang; Nils G Jacobson; Nezih Cereb; Soo Y Yang; Theresa L Murphy; Kenneth M Murphy
Journal:  Nat Immunol       Date:  2002-05-13       Impact factor: 25.606

Review 8.  Multiple myeloma: present and future.

Authors:  Mohamad A Hussein; Jaya V Juturi; Isador Lieberman
Journal:  Curr Opin Oncol       Date:  2002-01       Impact factor: 3.645

Review 9.  Imiquimod applied topically: a novel immune response modifier and new class of drug.

Authors:  R L Miller; J F Gerster; M L Owens; H B Slade; M A Tomai
Journal:  Int J Immunopharmacol       Date:  1999-01

Review 10.  The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase.

Authors:  C E Cameron; C Castro
Journal:  Curr Opin Infect Dis       Date:  2001-12       Impact factor: 4.915
View more
  10 in total

1.  Discovery of novel immunostimulants by dendritic-cell-based functional screening.

Authors:  Norikatsu Mizumoto; Jimin Gao; Hironori Matsushima; Yasushi Ogawa; Hiroaki Tanaka; Akira Takashima
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

2.  Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.

Authors:  Krishnan V Chakravarthy; Adela C Bonoiu; William G Davis; Priya Ranjan; Hong Ding; Rui Hu; J Bradford Bowzard; Earl J Bergey; Jacqueline M Katz; Paul R Knight; Suryaprakash Sambhara; Paras N Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

Review 3.  Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.

Authors:  Piyusha P Pagare; Aref Rastegar; Osheiza Abdulmalik; Abdelsattar M Omar; Yan Zhang; Andrew Fleischman; Martin K Safo
Journal:  Expert Opin Ther Pat       Date:  2021-11-01       Impact factor: 6.714

Review 4.  Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.

Authors:  Martin K Safo; Gregory J Kato
Journal:  Hematol Oncol Clin North Am       Date:  2014-01-21       Impact factor: 3.722

5.  Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.

Authors:  Alberto Fernández-Tejada; Eric K Chea; Constantine George; Jeffrey R Gardner; Philip O Livingston; Govind Ragupathi; Derek S Tan; David Y Gin
Journal:  Bioorg Med Chem       Date:  2014-09-17       Impact factor: 3.641

Review 6.  Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only target.

Authors:  Francesco Di Virgilio
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

7.  Immunomodulatory effects of Potentilla indica and Dendrophthoe pentandra on mice splenocytes and thymocytes.

Authors:  Hui Ying Ang; Tamilselvan Subramani; Swee Keong Yeap; Abdul Rahman Omar; Wan Yang Ho; Mohd Puad Abdullah; Noorjahan Banu Alitheen
Journal:  Exp Ther Med       Date:  2014-04-02       Impact factor: 2.447

8.  Successful treatment of lower eyelid melanoma in situ.

Authors:  Andrew A Gassman; Joyce Yuan; Justin Koh; Timothy A Miller
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-06-06

9.  Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.

Authors:  Alberto Fernández-Tejada; Derek S Tan; David Y Gin
Journal:  Acc Chem Res       Date:  2016-08-28       Impact factor: 22.384

10.  Dendrophthoe pentandra (L.) Miq extract effectively inhibits inflammation, proliferation and induces p53 expression on colitis-associated colon cancer.

Authors:  Agustina Tri Endharti; Adisti Wulandari; Anik Listyana; Eviana Norahmawati; Sofy Permana
Journal:  BMC Complement Altern Med       Date:  2016-09-26       Impact factor: 3.659
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.